ID | 116349 |
Author |
Bando, Hiroshi
Tokushima University|Japan Low Carbohydrate Diet Promotion Association|Sakamoto Hospital
KAKEN Search Researchers
Iwatsuki, Noboru
Sakamoto Hospital
Sakamoto, Kazuki
Sakamoto Hospital
Ogawa, Tomoya
Sakamoto Hospital
|
Keywords | Xultophy
Insulin Degludec and Liraglutide
Type 2 Diabetes Mellitus
Meal Tolerance Test
Postprandial Hyperglycemia
|
Content Type |
Journal Article
|
Description | The case is a 69-year-old male patient with Type 2 Diabetes Mellitus (T2DM) for 21 years. His diabetic control was not so satisfactory, and his HbA1c value increased in spring 2021. Then, he started Xultophy (IDegLira), which includes a fixed ratio of two agents of basal degludec and liraglutide. Just after providing Xultophy, the daily profile of blood glucose decreased from 179-400 mg/dL to 112-171 mg/dL, with remarkable clinical efficacy. He usually takes 80g of carbohydrates in breakfast, and the meal tolerance test (MTT) was challenged. As carbohydrate loading was given 100-75-50-0%, postprandial hyperglycemia at 60-min showed 277-219-159-133 mg/dL, respectively.
|
Journal Title |
Asploro Journal of Biomedical and Clinical Case Reports
|
ISSN | 25820370
|
Publisher | Asploro
|
Volume | 4
|
Issue | 2
|
Start Page | 145
|
End Page | 152
|
Published Date | 2021-08-12
|
Rights | This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
|
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
Publisher
|
departments |
Medical Sciences
|